Importantly, we observed that AR silencing reduced the VEGF synthesis in LNCaP as well as in C4-2 and 22RV1 cells (Figure 3B), demonstrating that VEGF is still regulated by AR in advanced prostate cancers. This evidence concerns the gene VEGFA and prostate cancer.